INTT vs NVDA

INTT exhibits a severe divergence between its market price and fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock has seen a massive 167.8% price increase over the last year, this rally is unsupported by deteriorating fundamentals, including negative YoY revenue growth (-10.30%) and negative earnings growth (-19.70%). The company is currently unprofitable with a negative ROE and profit margin, and insider activity is bearish with the CEO selling shares. The current valuation appears speculative and disconnected from the company's operational decline.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.